Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $73.0350 (-3.43%) ($73.0350 - $75.7550) on Fri. Jun. 23, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.47% (three month average) | RSI | 57 | Latest Price | $73.0350(-3.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.5% a day on average for past five trading days. | Weekly Trend | LGND advances 2.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(43%) XBI(42%) XAR(40%) VFMO(37%) XHB(36%) | Factors Impacting LGND price | LGND will decline at least -1.235% in a week (0% probabilities). UUP(-25%) TBT(-22%) VXX(-20%) VIXM(-8%) ARKG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.235% (StdDev 2.47%) | Hourly BBV | -2.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $74.19 | 5 Day Moving Average | $76.22(-4.18%) | 10 Day Moving Average | $75.88(-3.75%) | 20 Day Moving Average | $74.19(-1.56%) | To recent high | -8.3% | To recent low | 6.2% | Market Cap | $1.174b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |